Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE)
Horm Res
.
2003;60(2):103-4.
doi: 10.1159/000071879.
Authors
Anders Juul
1
,
Sergio Bernasconi
,
Jean-Claude Carel
,
Peter E Clayton
,
Wieland Kiess
,
Sabine DeMuinck-Keizer Schrama
;
Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology
Affiliation
1
University Department of Growth and Reproduction, Rigshsopitalet, Copenhagen, Denmark.
[email protected]
PMID:
12876422
DOI:
10.1159/000071879
No abstract available
Publication types
Consensus Development Conference
Review
MeSH terms
Human Growth Hormone / administration & dosage*
Human Growth Hormone / adverse effects*
Humans
Neoplasms / chemically induced*
Substances
Human Growth Hormone